FHTX vs RF
Foghorn Therapeutics Inc (FHTX) versus RF (RF) — a side-by-side from cached financials, not a winner call.
Foghorn Therapeutics Inc (FHTX) is a biotechnology company listed on NASDAQ.
RF (RF) common stock.
Latest reported FHTX revenue for 2024-12-31 was $22.6M. Net income was -$86.6M. Revenue was down 33.8% from 2023-12-31 to 2024-12-31. FHTX currently screens at market cap $237.8M.
RF does not have a complete income-statement cache yet.
FHTX currently screens at market cap $237.8M. RF currently screens at market cap $0.
Not investment advice. Open the FHTX and RF stock pages for the full models.
Not investment advice.